Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (5), 504-508
- https://doi.org/10.1016/s0002-9149(01)01727-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cellsAtherosclerosis, 2000
- High apolipoprotein (apo) B and low apoA-i improve the prediction of fata myocardial infarction at all levels of cholesterol and triglycerides — mortality data from the amoris (apolipoprotein-related mortality risk) studyAtherosclerosis, 2000
- Pharmacological properties of ZD4522 — A new HMG-CoA reductase inhibitorAtherosclerosis, 2000
- Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery DiseaseCirculation, 2000
- Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)Circulation, 2000
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998
- Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993